
Advances
Expert opinion: Parkinson’s and the appendix
Dr Viviane Labrie describes the link between the appendix and Parkinson’s
READ MOREMore than 100,000 Canadians living with Parkinson’s will benefit from a new product to be launched in the country.
The drug known as ‘Xadago’, currently readily available in several countries across Europe, helps control motor symptoms and complications over a 24-month period.
Xadago will be the first new oral treatment for Parkinson’s in almost 15 years in Canada. On 21 March 2017 the Food and Drug Administration in the US approved the use of Xadago for the treatment of Parkinson’s as an add-on therapy to levodopa/carbidopa.
Dr Viviane Labrie describes the link between the appendix and Parkinson’s
READ MOREDid you know these famous people had a Parkinson’s connection?
READ MOREFrom coping with changing symptoms to keeping a positive attitude
READ MORE
Comments